NASDAQ : SBFM

Sunshine Biopharma, Inc. — Financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 3.33 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 645.57K

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Sunshine Biopharma, Inc. (SBFM) reported revenue of 35.35M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue35.35M36.31M34.87M24.09M4.35M228.43K
Cost of Revenue24.64M24.05M24.20M15.75M2.65M117.83K
Gross Profit10.71M12.26M10.67M8.34M1.70M110.60K
Selling, General & Admin14.81M15.33M14.94M10.83M9.48M1.87M
Research & Development237.75K604.31K933.90K1.86M811.86K672.21K
Other Operating Expenses514.60K469.31K387.00K289.74K55.23K
Operating Expenses15.91M16.73M16.48M13.12M10.37M2.55M
Operating Income-5.20M-4.48M-5.81M-4.79M-8.67M-2.44M
Interest Expense-8.77K-137.31K-39.41K-328.82K
Interest & Investment Income230.06K280.90K496.00K811.97K518.65K
Currency Exchange Gain (Loss)227.002.64K-44.08K-245.00-476.0050.00
EBT Excluding Unusual Items-4.97M-4.20M-5.37M-4.11M-8.20M-2.77M
Impairment of Goodwill-18.33M
Gain (Loss) on Sale of Assets-10.26K-10.26K
Asset Writedown-686.44K-1.75M
Legal Settlements103.32K
Other Unusual Items10.85K-9.67M
Pretax Income-5.56M-5.95M-5.37M-4.11M-26.51M-12.44M
Income Tax Expense270.94K21.61K-234.86K395.17K233.30K
Earnings From Continuing Operations-5.83M-5.98M-5.13M-4.51M-26.74M-12.44M
Net Income-5.83M-5.98M-5.13M-4.51M-26.74M-12.44M
Net Income to Common-5.83M-5.98M-5.13M-4.51M-26.74M-12.44M
Shares Outstanding (Basic)35.59K20.79K
Shares Outstanding (Diluted)35.59K20.79K
EPS (Basic)-163.91-287.48
EPS (Diluted)-163.91-287.48
Free Cash Flow-5.37M-5.51M-14.18M-8.86M-5.44M-1.83M
Free Cash Flow Per Share-150.96-264.88
Gross Margin30.30%33.76%30.59%34.61%39.04%48.42%
Operating Margin-14.71%-12.34%-16.67%-19.86%-199.61%-1,068.24%
Profit Margin-16.50%-16.46%-14.72%-18.70%-615.44%-5,444.41%
Free Cash Flow Margin-15.20%-15.16%-40.67%-36.76%-125.24%-800.75%
EBITDA-4.85M-4.15M-5.59M-4.64M-8.65M-2.43M
EBITDA Margin-13.72%-11.42%-16.02%-19.24%-199.03%
D&A For EBITDA349.67K332.07K223.53K149.15K25.16K12.74K
EBIT-5.20M-4.48M-5.81M-4.79M-8.67M-2.44M
EBIT Margin-14.71%-12.34%-16.67%-19.86%-199.61%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents13.75M9.12M9.69M16.29M21.83M2.05M
Short-Term Investments281.48K7.59K
Cash & Short-Term Investments14.03M9.12M9.69M16.29M21.83M2.05M
Accounts Receivable4.04M3.46M3.87M2.55M1.91M7.80K
Receivables4.04M3.46M3.87M2.55M1.91M7.80K
Inventory12.12M13.47M11.28M5.73M3.29M105.65K
Prepaid Expenses478.49K798.38K1.13M310.59K283.80K29.62K
Total Current Assets30.67M26.85M25.97M24.89M27.31M2.20M
Property, Plant & Equipment1.13M1.34M1.48M1.01M1.15M7.06K
Other Intangible Assets1.84M1.89M3.02M1.44M776.86K
Long-Term Deferred Tax Assets92.23K
Total Assets33.63M30.08M30.56M27.35M29.24M2.20M
Accounts Payable4.85M5.66M5.54M2.59M2.80M42.94K
Accrued Expenses48.29K
Current Portion of Leases202.52K215.64K207.76K118.67K123.03K
Current Income Taxes Payable268.28K268.28K268.28K299.87K373.19K
Other Current Liabilities295.80K295.80K295.80K2.55M3.63M
Total Current Liabilities5.62M6.44M6.31M5.55M6.93M91.23K
Long-Term Debt1.90M
Long-Term Leases475.82K596.78K744.72K539.03K642.23K
Long-Term Deferred Tax Liabilities48.73K43.03K
Total Liabilities6.09M7.04M7.06M6.14M7.62M1.99M
Common Stock2.39K4.91K2.58K14.0022.59K2.59K
Additional Paid-In Capital106.00M98.10M93.35M84.42M80.84M32.79M
Retained Earnings-77.82M-75.02M-69.04M-63.91M-59.40M-32.66M
Comprehensive Income & Other-658.93K-65.31K-829.96K696.11K161.85K-23.14K
Total Common Equity27.53M23.03M23.49M21.21M21.63M111.66K
Shareholders' Equity27.54M23.04M23.50M21.21M21.63M211.66K
Total Liabilities & Equity33.63M30.08M30.56M27.35M29.24M2.20M
Total Debt678.34K812.42K952.48K657.71K765.26K1.90M
Net Cash (Debt)13.35M8.31M8.73M15.63M21.06M152.76K
Net Cash Per Share375.20399.85
Filing Date Shares Outstanding193.87K24.53K13.54K
Total Common Shares Outstanding119.43K24.53K12.90K
Working Capital25.05M20.41M19.65M19.34M20.38M2.10M
Book Value Per Share230.48938.671,820.76
Tangible Book Value25.68M21.14M20.47M19.76M20.85M111.66K
Tangible Book Value Per Share215.05861.641,586.67
Machinery913.53K794.28K538.20K478.06K
Leasehold Improvements93.96K88.31K17.66K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-5.83M-5.98M-5.13M-4.51M-26.74M-12.44M
Depreciation & Amortization349.67K332.07K223.53K149.15K25.16K12.74K
Asset Writedown & Restructuring Costs686.44K1.75M18.33M
Stock-Based Compensation96.90K12.00K918.00K
Other Operating Activities10.26K10.26K-10.30K9.79M
Change in Accounts Receivable-1.31M-116.17K-2.34M-594.14K-524.49K-5.88K
Change in Inventory359.03K-1.64M-6.01M-2.37M42.98K-81.88K
Change in Accounts Payable47.22K-189.96K3.98M-1.36M3.36M-18.16K
Change in Income Taxes10.12K-812.08K-73.25K238.68K
Change in Other Net Operating Assets227.05K497.11K-2.45M-21.14K34.56K-2.88K
Operating Cash Flow-5.35M-5.33M-12.52M-8.78M-5.25M-1.83M
Capital Expenditures-19.14K-174.49K-1.66M-82.25K-193.98K
Cash Acquisitions-14.35M
Sale (Purchase) of Intangibles-164.59K-661.82K-322.26K-705.85K-111.02K
Other Investing Activities131.95K33.38K
Investing Cash Flow-183.74K-836.31K-1.98M-656.15K-14.62M
Long-Term Debt Issued3.32M
Total Debt Issued3.32M
Long-Term Debt Repaid-125.99K-1.93M-475.32K
Total Debt Repaid-125.99K-1.93M-475.32K
Net Debt Issued (Repaid)-125.99K-1.93M2.84M
Issuance of Common Stock8.53M4.75M12.08M4.09M43.56M
Repurchase of Common Stock-3.14M-541.14K-99.00K
Other Financing Activities-2.06M61.50K
Financing Cash Flow8.53M4.75M8.94M3.43M39.47M2.90M
Foreign Exchange Rate Adjustments450.79K855.75K-1.04M471.58K183.91K-20.27K
Net Cash Flow3.44M-563.22K-6.61M-5.53M19.78M1.06M
Free Cash Flow-5.37M-5.51M-14.18M-8.86M-5.44M-1.83M
Free Cash Flow Margin-15.20%-15.16%-40.67%-36.76%-125.24%-800.75%
Free Cash Flow Per Share-150.96-264.88
Levered Free Cash Flow-2.01M-4.63M-12.39M-8.20M-4.35M-910.42K
Unlevered Free Cash Flow-2.01M-4.63M-12.38M-8.12M-4.33M-704.91K
Cash Interest Paid8.13K48.29K38.12K
Cash Income Tax Paid582.48K
Change in Working Capital-663.35K-1.45M-7.63M-4.42M3.15M-108.80K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization568.03K6.03M6.00M6.95M14.34M28.06M
Enterprise Value-12.78M-2.40M-5.64M-11.22M-26.23M29.30M
Last Close Price2.93246.00600.00108,600.00256,000.004,676,000.00
Forward PE38.250.26
PS Ratio0.020.170.170.293.30122.82
PB Ratio0.010.260.260.330.66132.55
P/TBV Ratio0.020.280.290.350.69251.26
EV/Sales Ratio128.25
Debt / Equity Ratio0.030.040.040.030.048.98
Net Debt / Equity Ratio-0.48-0.36-0.37-0.74-0.97-0.72
Net Debt / EBITDA Ratio2.752.001.563.372.440.06
Net Debt / FCF Ratio2.481.510.621.763.870.08
Asset Turnover1.081.201.200.850.280.14
Inventory Turnover1.961.942.853.491.561.82
Quick Ratio3.211.952.153.393.4222.59
Current Ratio5.464.174.114.483.9424.07
Return on Equity (ROE)-21.92%-25.68%-22.97%-21.04%-244.92%
Return on Assets (ROA)-9.91%-9.23%-12.55%-10.57%-34.48%-93.90%
Return on Capital Employed (ROCE)-18.60%-18.90%-24.00%-22.00%-38.90%-115.60%
Earnings Yield-5,594.13%-99.03%-85.59%-64.83%-186.55%-44.33%
FCF Yield-945.71%-91.24%-236.41%-127.44%-37.96%-6.52%